691 – Dolutegravir and Incident Diabetes Mellitus in West African People Living With HIV
Background Diabetes mellitus (DM) is a growing complication among people living with HIV (PLHIV), driven by traditional risk factors including age or obesity, as well as HIV-related factors such as exposure to certain antiretroviral therapy (ART). Dolutegravir (DTG), now the recommended first-line regimen in most settings, has been associated with metabolic disorders including weight gain,…